Pfizer expects revenue from the COVID-19 vaccine, co-developed by BioNTech, will reach $33.5 billion this year — a 29% jump from the previously estimated $26 billion.Why it matters: This vaccine, which has dramatically slowed the coronavirus pandemic, is on p…
Read More
Spread the love